Dschietzig, T.B. and Salama, G. 2024. Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378. Global Cardiology. 2, 4 (Dec. 2024). DOI:https://doi.org/10.4081/cardio.2024.56.